CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity (Q39715181)
Jump to navigation
Jump to search
scientific article published on 13 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity |
scientific article published on 13 April 2010 |
Statements
1 reference
CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity (English)
1 reference
Cheng-Jung Lai
1 reference
Rudi Bao
1 reference
Xu Tao
1 reference
Jing Wang
1 reference
Ruzanna Atoyan
1 reference
Hui Qu
1 reference
Da-Gong Wang
1 reference
Ling Yin
1 reference
Maria Samson
1 reference
Jeffrey Forrester
1 reference
Brian Zifcak
1 reference
Guang-Xin Xu
1 reference
Steven DellaRocca
1 reference
Hai-Xiao Zhai
1 reference
Xiong Cai
1 reference
William E Munger
1 reference
Mitchell Keegan
1 reference
Carmen V Pepicelli
1 reference
Changgeng Qian
1 reference
13 April 2010
1 reference
1 reference
3647-3656
1 reference
Identifiers
1 reference